Company page

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. (ticker: XBIO) is a public company operating in the American market, with a market capitalization of approximately $6.4 million. The company focuses on developing innovative therapeutics and drug delivery technologies. Xenetic aims to advance its proprietary platforms to enhance patient outcomes in various medical fields.